Abstract. Chronic microglial activation endangers neuronal survival through the release of various pro-inflammatory and neurotoxic factors. As such, negative regulators of microglial activation have been considered as potential therapeutic candidates to reduce the risk of neurodegeneration associated with inflammation. Uncaria rhynchophylla (U. rhynchophylla) is a traditional oriental herb that has been used for treatment of disorders of the cardiovascular and central nervous systems. Hirsutine (HS), one of the major indole alkaloids of U. rhynchophylla, has demonstrated neuroprotective potential. The aim of the present study was to examine the efficacy of HS in the repression of inflammation-induced neurotoxicity and microglial cell activation. In organotypic hippocampal slice cultures, HS blocked lipopolysaccharide (LPS)-related hippocampal cell death and production of nitric oxide (NO), prostaglandin (PG) E 2 and interleukin-1β. HS was demonstrated to effectively inhibit LPS-induced NO release from cultured rat brain microglia. The compound reduced the LPS-stimulated production of PGE 2 and intracellular reactive oxygen species. HS significantly decreased LPS-induced phosphorylation of the mitogen-activated protein kinases and Akt signaling proteins. In conclusion, HS reduces the production of various neurotoxic factors in activated microglial cells and possesses neuroprotective activity in a model of inflammationinduced neurotoxicity.
Introduction
Immune and inflammatory responses in the central nervous system (CNS) are principally mediated by microglia. These responses are activated during neuropathological conditions and restore CNS homeostasis (1) . The activation of microglia involves proliferation, migration to the injury site, increased expression of immunomodulators and transformation into phagocytes (1, 2) . Activated microglia also promote neuronal injury through the release of proinflammatory and cytotoxic factors, including cytokines, nitric oxide (NO) and reactive oxygen species (ROS) (2) . Chronic microglial activation has been implicated in neuronal destruction associated with various neurodegenerative diseases, including Alzheimer's and Parkinson's (3) . Therefore, downregulation of negative-regulatory mechanisms to reduce the activation of microglial cells is essential to avoid excessive CNS inflammatory processes (4) . The identification of agents that target over-activated microglial cells is essential for the reduction of neuronal destruction associated with neurodegenerative diseases.
Uncaria rhynchophylla is a traditional oriental herb that has been used for treatment of disorders of the cardiovascular and central nervous systems (5) . Hirsutine (HS) is a major indole alkaloid of U. rhynchophylla. HS has been reported to have antihypertensive and antiarrhythmic activities through its effects on intracellular Ca 2+ levels in rat aorta and the action potential in cardiac muscle (6, 7) . In a previous study, HS was demonstrated as effective for the protection of rat cardiomyocytes from hypoxia-induced cell death (8) . Studies using animal models have revealed that extracts isolated from U. rhynchophylla demonstrate neuroprotective potential against diverse neuronal injuries associated with excitotoxicity, amnesia, epileptic seizures and Parkinson's and Alzheimer's disease (9) (10) (11) (12) (13) . In vitro studies on the neuroprotective roles of HS have demonstrated that the compound attenuates glutamate-induced cell death in PC12 and cerebellar granule cells (14, 15) . Based on these studies, components of U. rhynchophylla have been proposed to act as neuroprotective agents. However, the efficacy of the compounds on neuroinflammation control has been largely unexplored. The purpose of the present study was to examine Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits inflammation-mediated neurotoxicity and microglial activation HWAN 
LPS treatment and assessment of neuronal damage.
Neurotoxicity was evaluated by the uptake of the fluorescent dye propidium iodide (PI) as previously described (17, 18) . Briefly, LPS (10 µg/ml) was applied to hippocampal cultures with or without pretreatment with HS. Following LPS treatment, the culture medium was collected and subjected to the nitrite assay prior to being replaced with fresh serum-free medium containing 5 µg/ml PI. Neuronal death was observed within 30-60 min of PI addition. PI-stained images were captured using a laser scanning microscope (LSM 510; Carl Zeiss, Cambridge, UK) and the observed PI-uptake areas were measured using confocal microscopy with LSM 510 software (release 3.2; Carl Zeiss). All the data were background subtracted using the fluorescence emission originated from a region on the insert containing no tissue. For immunofluorescent staining of neurons, hippocampal slices were fixed in 4% paraformaldehyde and stained with Alexa fluor 488-conjugated mouse anti-NeuN monoclonal antibody (Chemicon International, Temecula, CA, USA). The immunostained images were observed under a Carl Zeiss LSM 510 microscope.
Primary microglia culture. Primary microglial cells were prepared from cerebral cortices of one-day-old rat pups (Orient) as described previously (19, 20) . Cells reached confluence at 12-14 days and flasks were agitated to remove the microglia. The detached cells were incubated for 1 h and the non-adherent cells were removed. The adherent microglial cells were cultured for 24 h and the purity of the cultures was routinely >95%, as judged by immunostaining with an anti-OX-42 antibody (Chemicon). The cells were pretreated with HS in fresh medium containing 0.1% fetal bovine serum for 30 min prior to the addition of LPS.
Nitrite assay. Nitrite in culture supernatants was measured as an indicator of NO production. An aliquot of the culture supernatant was mixed with a volume of Griess reagent (Molecular Probes, Eugene, OR, USA) and the absorbance at 570 nm was determined using a microplate reader. Sodium nitrite (0-100 µM) was used as a standard to assess nitrite concentrations.
Cell viability assay. For the cell viability assay, cultures were incubated in MTT solution (1 mg/ml; Sigma) in two volumes of culture medium for 1 h at 37˚C. The MTT solution was then removed, the cells were dissolved in dimethyl sulfoxide (150 µl) and optical density of the samples was measured at 570 nm using a microplate reader.
IL-1β and prostaglandin (PG) E 2 assays.
Following each treatment, culture medium was collected in microcentrifuge tubes and centrifuged at 10,000 x g for 10 min. The supernatants were assayed for secreted mediators using PGE 2 and rat IL-1β immunoassay kits (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions.
Intracellular ROS assay. Presence of intracellular ROS was measured using a non-fluorescent 2',7'-dichlorofluorescein (DCFH-DA; Molecular Probes) dye as described previously (21 Statistical analysis. For statistical analysis, data were expressed as the mean ± SEM from three independent experiments. The Student's paired t-test was used for statistical analyses which were performed using SPSS software (version 13.0, SPSS Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Protection against LPS-mediated neuronal damage.
In an effort to develop neuroprotective drugs, strategies to ameliorate the inflammatory microenvironment, which indirectly damages neurons via glial cell mediators, are promising (4). We previously established an experimental condition to determine the effect of LPS exposure on neuronal damage in organotypic hippocampal slice cultures (20) . In the present study, slice cultures exposed to LPS for 72 h exhibited marked PI uptake in the hippocampus in comparison to untreated control slices (Fig. 1A) . The increased PI uptake was markedly blocked by treatment with HS ( Fig. 1A and B), in parallel with the inhibition of LPS-induced production of various proinflammatory mediators, including NO, PGE 2 and IL-1β (Fig. 1D-F) . Reduced immunoreactivity of NeuN, a neuronal-specific marker, accompanied with elevated PI fluorescence indicated that loss of neurons resulted from the LPS insult (Fig. 1C) . Treatment with HS restored immunoreactivity of NeuN and simultaneously decreased PI fluorescence (Fig. 1C) . Together, these results indicate that HS has protective effects against inflammation-induced neurotoxicity.
Suppression of LPS-stimulated microglial inflammatory responses.
To determine the mechanisms of the anti-inflammatory effects of HS in more detail, various mediators of microglial activation were measured. The effects of treatment with HS on secretion of proinflammatory mediators from microglial cells were tested. HS suppressed LPS-induced nitrite release from microglial cells in a dose-dependent manner ( Fig. 2A) . Cell viability, as measured using the MTT assay, was not significantly affected at ≤20 µM (Fig. 2B) . HS appeared to decrease cell viability of activated microglia to a degree at 30 µM (Fig. 2B) , however, it alone had no effect on basal NO release at <30 µM (Fig. 2C) . .05 vs. LPS-only treated group. LPS was previously reported to cause activation-induced cell death in microglia (33) . Therefore, cell viability, as measured using the MTT assay, was often reduced by LPS. HS, hirsutine; LPS, lipopolysaccharide. Effect of HS on secretion of PGE2 and production of ROS. HS was found to reduce LPS-induced production of PGE 2 (Fig. 3A) . Intracellular ROS act as second messengers in the regulation of the LPS-stimulated production of neurotoxic factors in microglia (22) . The ROS levels measured using DCFH-DA revealed that pretreatment with HS decreased LPS-induced ROS production in microglia (Fig. 3B) .
HS inhibits multiple signaling pathways. Multiple signaling pathways, including those involving mitogen-activated protein kinases (MAPKs) and Akt, have been reported to be involved in LPS-induced signal transduction, which results in the induction of proinflammatory gene expression (23) (24) (25) (26) . The present study demonstrates that HS markedly inhibited the LPS-enhanced phosphorylation of p44/42 MAPK, p38, SAPK/ JNK (Fig. 4) . Among the kinases, phosphorylation of SAPK/ JNK was reduced to the greatest extent by HS (Fig. 4) . Taken together, the present data indicate that the anti-inflammatory action of HS in microglia is, at least in part, mediated by the inhibition of these signaling pathways.
Discussion
In the present study, HS, one of the major alkaloids of U. rhynchophylla, effectively repressed diverse inflammatory mediators induced by LPS, including NO, PGE 2 , intracellular ROS and phosphorylation of MAPKs and Akt in primary microglial cell culture. Beyond the control of microglial activation, more direct efficacy of HS against inflammation-induced neurotoxicity was observed in hippocampal slice cultures. As such, our results demonstrate that HS may be useful in ameliorating brain disorders associated with uncontrolled microglia-mediated inflammatory responses. Taken together with previous studies on anti-inflammatory actions of rhynchophylline and isorhynchophylline (27, 28) , the present study supports a pharmacological potential for U. rhynchophylla and its active components in manipulating neuroinflammation associated with diverse neuropathologies. Among the diverse neuroprotective activities of U. rhynchophylla, antioxidant properties are well established (12, 14, 29) . In previous studies, U. rhynchophylla exhibited the ability to reduce levels of free radicals in rat brain and increase glutathione levels in PC12 cells (12, 29) . U. rhynchophylla inhibits the NMDA receptor-activated ion current in hippocampal neurons (10) . Additionally, U. rhynchophylla inhibits the aggregation of amyloid β protein, a pathological hallmark of Alzheimer's disease (9) . Neuroprotective potential conferred by HS has also been explained with its inhibitory capacities on oxidative stress, ion channels and Ca 2+ influx (14, 15, 30) . However, little is known regarding the effects of U. rhynchophylla and its active compounds on microglia.
According to a previous study, U. rhynchophylla reduces microglial activation in the region of neuronal damage caused by kainic acid administration (13) . In the present study, U. rhynchophylla reduced ED1-and inducible NO synthaseimmunoreactive cell counts in rat brain, demonstrating that U. rhynchophylla may suppress microglia activation in vivo. Numerous studies have demonstrated an inhibitory function of rhynchophylline-type alkaloids of U. rhynchophylla in microglial activation in vitro (27, 28) . Rhynchophylline and isorhynchophylline have been shown to suppress the release of NO and proinflammatory cytokines and the phosphorylation of p44/42 and p38 MAPKs in LPS-activated N9 microglial cell lines (28) . 
A B
A detailed study on alkaloids from U. rhynchophylla previously identified that geissoschizine methyl ether, a corynanthean-type indole alkaloid, is a potent acetylcholinesterase inhibitor and may be a suitable candidate for Alzheimer's disease (31) . Matsumoto et al demonstrated that isorhynchophylline regulates neurotransmission by suppressing the serotonin 5-hydroxytryptamine 2A receptor function in the brain by competitive antagonism (32) . Studies of alkaloids, including the present study, may broaden understanding of the pharmacological value of these compounds of U. rhynchophylla in the treatment of neuropathologies, by highlighting various beneficial roles in neuronal survival, synaptic plasticity and microglial activation in the CNS. In this sense, the present results may stimulate further investigation to confirm novel neuropharmacological roles of each individual compound of U. rhynchophylla.
